We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLL
RNS Number : 5159K
Cello Health PLC
14 December 2018
14 December 2018
Cello Health plc
("Cello" or the "Company")
Block Listing Update
Further to the announcement by the Company on 5 June 2018, the Company announces that a total of 51,988 new ordinary shares of 10p each in the share capital of the Company ("Ordinary Shares") have been issued and allotted since that date pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010 and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.
Enquires
Cello Health 020 7812 8460 Mark Scott, Chief Executive Mark Bentley, Finance Director Cenkos Securities 020 7397 8900 Mark Connelly Harry Hargreaves
BLOCK LISTING SIX MONTHLY RETURN
Name of applicant: Cello Health plc Name of scheme: PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010 ------------------------------------------- Period of return: From: 31 May 2018 To: 31 November 2018 -------- --------------- ---- -------------------- Balance of unallotted securities under scheme(s) from previous return: 663,596 ------------------------------------------- Plus: The amount by which the - block scheme(s) has been increased since the date of the last return (if any increase has been applied for): ------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): (51,988) ------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 611,608 ------------------------------------------- Name of contact: Mark Bentley, Group Finance Director ------------------------------------------- Telephone number of contact: 020 7812 8460 -------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRZMMMZLDZGRZG
(END) Dow Jones Newswires
December 14, 2018 04:24 ET (09:24 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions